Central Nervous System
Panel 23 (Live SA-CME) - An Evidence-Driven Guide to Thinking Through Radiation and Surgery for Brain Metastasis
3:15 PM - 4:45 PM
Location: Room 006
Session Type: Panel
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits
To receive Live SA-CME credit, you must add this session to your registration for an additional fee. For Live SA-CME credit you must present your ticket at the door and complete the online assessment. Space is limited, so please register early. Please note that events and fees are subject to change.
For CME credit you DO NOT NEED TO REGISTER FOR THIS SESSION.
Improving systemic therapies for metastatic disease have led to an increasing incidence of brain metastasis for patients with solid malignancies. Patients diagnosed with brain metastasis, meanwhile, are benefiting from a rapidly proliferating body of CNS-directed research that, appropriately applied, can lead to improved survival and quality of life. In selected cases of brain metastasis, radiosurgery and hypofractionated stereotactic radiotherapy (SRT) may be used either in lieu of, or in combination with invasive neurosurgery. The appropriate selection of therapy, and in the case of combined therapy, the sequencing - neoadjuvant versus adjuvant radiosurgery - should be predicated upon the risk/benefit ratio of each to the individual. This requires familiarity with novel contemporary observations culled from a large body of recent literature. This session is designed to familiarize the audience with the key considerations necessary to individualize decision-making and to equip them with the necessary skills for competent treatment of patients eligible for neurosurgery and/or radiosurgery for brain metastasis. A case-based approach will be used to contextualize novel concepts and facilitate learning.
- Apply optimal sequencing of dual modality therapy for a given case scenario of brain metastasis.
- Describe optimal treatment planning techniques for patients with intact, pre-operative and post-operative brain metastasis.
- Compare and contrast risks and benefits of radiosurgery versus neurosurgery versus combined therapy for brain metastasis.
3:15 PM - 3:35 PM
Radiosurgery versus Neurosurgery (or both?): the evidence
Speaker: – Fox Chase Cancer Center
3:35 PM - 3:55 PM
Post operative SRS
Speaker: – Memorial Sloan Kettering Cancer Center
3:55 PM - 4:15 PM
Technique for post-operative treatment planning
Speaker: – Stanford Department of Radiation Oncology
4:15 PM - 4:35 PM